Results 211 to 220 of about 678,448 (346)

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals

Hepatology Research, Volume 55, Issue 5, Page 631-637, May 2025.
Direct‐acting antiviral treatment for patients with type C liver cirrhosis not only improves the liver function, but also reduces the myostatin level, which is associated with muscle atrophy. Therefore, antiviral therapy may improve sarcopenia associated with chronic liver disease.
Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi   +9 more
wiley   +1 more source

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

Hepatology, 2017
J. Bajaj, Z. Kassam, A. Fagan, E. Gavis, E. Liu, I. Cox, Raffi Kheradman, D. Heuman, Jessica Wang, Thomas Gurry, Roger Williams, M. Sikaroodi, M. Fuchs, E. Alm, Binu V. John, L. Thacker, A. Riva, Mark Smith, S. Taylor-Robinson, P. Gillevet   +19 more
semanticscholar   +1 more source

Understanding hepatic encephalopathy [PDF]

Intensive Care Medicine, 2017
Dominique Thabut, Dominique Thabut, Nicolas Weiss, Nicolas Weiss, Rajiv Jalan   +4 more
openaire   +4 more sources

Pancreatic congestion is associated with exocrine pancreatic function in liver cirrhosis

Hepatology Research, Volume 55, Issue 5, Page 685-695, May 2025.
Abstract Aim Portal hypertension resulting from liver cirrhosis (LC) can lead to pancreatic congestion and impaired insulin secretion. Therefore, this prospective study aimed to assess the association between pancreatic congestion and exocrine pancreatic function in patients with LC.
Masahito Kokubu, Yoshiki Imamura, Teru Kumagi, Masashi Hirooka, Yuki Numata, Yusuke Okujima, Sho Ishikawa, Kaori Marui‐Sato, Mitsuhito Koizumi, Yoichi Hiasa   +9 more
wiley   +1 more source

Involvement of the ADAMTS13–von Willebrand factor axis in acute kidney injury in mice with liver cirrhosis

Hepatology Research, EarlyView.
Abstract Aim Hepatorenal syndrome‐induced acute kidney injury (AKI) comprises AKI and liver cirrhosis (LC) and is a risk factor for poor prognoses of patients with LC. Decreased a disintegrin‐like metalloproteinase with thrombospondin type 1 motif 13 (ADAMTS13) activity and increased von Willebrand factor (vWF) antigen levels are associated with LC ...
Masayoshi Takami, Norihisa Nishimura, Kosuke Kaji, Nobuyuki Yorioka, Hiroyuki Masuda, Hiroaki Takaya, Koh Kitagawa, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji   +9 more
wiley   +1 more source

Cachexia is an independent predictor of mortality in patients with cirrhosis

Hepatology Research, EarlyView.
Abstract Aim Cachexia is a systemic response syndrome characterized by disabling wasting during disease progression. This study aimed to elucidate factors associated with cachexia in patients with cirrhosis and to examine the impact of cachexia on patient survival.
Takao Miwa, Goki Suda, Ryosuke Tateishi, Tatsunori Hanai, Masatsugu Ohara, Yasuhiro Hagiwara, Shinji Unome, Kazuya Okushin, Mina Nakagawa, Naoya Sakamoto, Masahito Shimizu   +10 more
wiley   +1 more source

Hepatic encephalopathy as an indication or contraindication to liver transplant? [PDF]

Metab Brain Dis
Lauridsen MM, Bajaj JS.
europepmc   +1 more source

Nationwide survey of patients with acute liver failure and late‐onset hepatic failure in Japan seen between 2016 and 2021

Hepatology Research, EarlyView.
Abstract Aim A nationwide survey was conducted to clarify the recent status of patients with acute liver failure (ALF) and late‐onset fulminant hepatitis (LOHF) in Japan. Methods Two‐step surveys were performed annually targeting 782 hospitals, focusing on patients meeting the Japanese diagnostic criteria.
Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida, Akio Ido, Yasuhiro Takikawa, Keisuke Kakisaka, Naoya Kato, Kazuaki Chayama, Kazuaki Inoue, Mureo Kasahara, Shuji Terai, Hiromasa Ohira, Isao Sakaida, Taro Takami, Kiyoshi Hasegawa, Masanori Abe, Masahito Shimizu, Hitoshi Yoshiji, Takuya Genda, Ayano Inui, Ryuzo Abe, Hajime Takikawa, Atsushi Tanaka, Satoshi Mochida   +23 more
wiley   +1 more source

Ammonia and beyond - biomarkers of hepatic encephalopathy. [PDF]

Metab Brain Dis
Gallego JJ, Ballester MP, Fiorillo A, Casanova-Ferrer F, López-Gramaje A, Urios A, Arenas YM, Ríos MP, Durbán L, Megías J, San-Miguel T, Benlloch S, Lluch P, Jalan R, Montoliu C.   +14 more
europepmc   +1 more source

Validation of PBC‐10 in Japanese patients with primary biliary cholangitis

Hepatology Research, EarlyView.
This study validates the Japanese version of the PBC‐10, a short‐form health‐related quality of life (HRQOL) assessment tool for patients with primary biliary cholangitis (PBC). The findings confirm its reliability and strong correlation with the PBC‐40, supporting its use for rapid clinical screening of HRQOL impairments in Japanese patients. Abstract
Akihito Takeuchi, Masanori Abe, Sachiko Furukawa, Tadashi Namisaki, Atsushi Takahashi, Kazumichi Abe, Kentaro Kikuchi, Ryo Miura, Naoko Tachizawa, Yoshinari Asaoka, Akinobu Takaki, Yoshiyuki Ueno, Akira Honda, Shuji Terai, Atsumasa Komori, Hiromasa Ohira, Hitoshi Yoshiji, Atsuko Yonezawa, Atsushi Tanaka   +18 more
wiley   +1 more source